FindTrial
Sign In

Exploring the pathogenesis of hemorrhagic fever with renal syndrome

Exploring the pathogenesis of hemorrhagic fever with renal syndrome

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-OOC-14005479
Enrollment
Unknown
Registered
2014-10-08
Start date
2014-02-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hemorrhagic fever with renal syndrome

Interventions

The mild:No
The moderate group :No
The severe group:No
The critical group:No
Kidney damage group:No
No kidney damage group:No

Sponsors

The First Affiliated Hospital of Harbin Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
15 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Male and female aged 15 to 80 years old; 2. In line with the clinical diagnosis of hemorrhagic fever with renal syndrome in patients admitted ; 3. Able and willing to provide signed informed consent.

Exclusion criteria

Exclusion criteria: 1. has been suffering from heart failure, atrial fibrillation, and other cardiac diseases; 2. has been suffering from renal insufficiency.

Design outcomes

Primary

MeasureTime frame
B-type natriuretic peptide;Viral gene sequencing;C-type natriuretic peptide;Blood Pressure;integrin;—

Secondary

MeasureTime frame
NT-proBNP;Interleukin, IL;Interferon, IFN;Growth factor, GF (EGF\VEGF\PDECGF\TGF-alpha, etc.);Chemokine family;Renin-angiotensin-aldosterone system, RAAS;Blood Analysis;Biochemical indices of liver function;Biochemical indices of renal function;Blood electrolyte;Cardiac enzymes;Urine volume;Urinalysis;Ultrasonography (urinary system, heart, abdomen, chest);Pulmonary CT;Electrocardiography;Hemorrhagic fever antibodies;—

Countries

China

Contacts

Public ContactYinghua Lan
lanyinghua@yahoo.com.cn+86 13796050629

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026